丂

僸僩巕媨摦柆慻怐攟梴宯偵偍偗傞僄僗僩儘僎儞偺撪枌旍岤梷惂婡彉
乗擔杮峏擭婜堛妛夛妛弍彠椼徿傪庴徿偟偰乗

惗懱嵽椏岺妛尋媶強婡擻暘巕晹栧丂彆嫵庼丂搶丂丂丂丂丂梞

丂暵宱屻偺彈惈偱偼怱嬝峓嵡傗擼峓嵡側偳偑崅昿搙偵敪徢偡傞偑丆僄僗僩儘僎儞曗廩椕朄乮Hormone Replacement Therapy:HRT乯偵傛偭偰栺敿暘偵尭彮偡傞偺偱丆棏憙婡擻偑攑愨偟丆僄僗僩儘僎儞暘斿擻偑徚幐偡傞偨傔偵偙傟傜偺昦曄偑敪尰偡傞偺偱偁傠偆偲峫偊傜傟偰偄傞丅偟偐偟側偑傜丆徻嵶偵偮偄偰偼丆側偍晄柧偱偁傞丅変乆偼杮妛堛妛晹嶻晈恖壢妛島嵗偲偺嬞枾側楢実偺壓偵嫟摨尋媶傪峴偆偙偲偵傛偭偰丆暵宱屻偵崅昿搙偵敪尰偡傞旍岤惈寣娗昦曄偺敪徢丒恑揥婡彉偺夝柧偲怴偟偄奣擮偵婎偯偔恌抐丒帯椕朄偺妋棫傪栚巜偟偰偄傞丅撪旂嵶朎偵偍偄偰嶻惗偝傟傞NO偲PGI俀偼丆僸僩巕媨摦柆偱偺嬊強弞娐傗暯妸嬝嵶朎憹怋偺挷愡場巕偲偟偰廳梫側栶妱傪墘偠偰偄傞偙偲丆傑偨丆撪旂嵶朎偵偍偗傞NO偲PGI俀嶻惗偼彮側偔偲傕堦晹丆僄僗僩儘僎儞偵傛偭偰惂屼偝傟偰偄傞偙偲傪柧傜偐偵偟偨丅傑偨丆偙偺惂屼婡峔偺攋抅丆NO偲PGI俀嶻惗偺徚幐偍傛傃乛傑偨偼NO偲PGI俀偲偺憡屳嶌梡偺寚擛偑丆僸僩巕媨摦柆偵偍偗傞旍岤惈寣娗昦曄偺敪徢丒恑揥偲枾愙偵娭楢偡傞偙偲偵偮偄偰傕偡偱偵曬崘偟偨丅堦曽丆NO崌惉峺慺偺撪場惈慾奞暔幙乮NG乚monomethyl乚L乚arginine:L乚NMMA側傜傃偵asymmetrical NG, NG乚dimethyl乚L乚arginine:ADMA乯偑撪旂嵶朎偵偍偗傞NO惗崌惉傪惂屼偟偰偍傝丆壗傜偐偺尨場偱乮嫲傜偔偼撪旂嵶朎枌傪夘偡傞偙傟傜撪場惈慾奞暔幙偺庢崬傒偺槾恑乯偙傟傜慾奞暔幙偑撪旂嵶朎撪偵拁愊偡傞偲丆NO嶻惗偼掅壓偟丆偦偺寢壥丆嫮椡側vasoconstrictor偍傛傃mitogen偲偟偰椙偔抦傜傟偰偄傞endothelin乚1偺寣娗暻儗儀儖偺憹壛傪棃偡丅偙偺偙偲傕丆旍岤惈寣娗昦曄偺敪徢丒恑揥婡彉偲枾愙偵娭傢傞壜擻惈傪帵嵈偟偨丅埲忋偺惉壥傪摜傑偊丆崱夞庴徿懳徾偲側偭偨尋媶偱偼丆僄僗僩儘僎儞偑撪旂嵶朎偵偍偗傞NO偲PGI俀嶻惗槾恑丆傂偄偰偼嫮椡側嵶朎憹怋梷惂妶惈傪桳偡傞cyclic GMP偲cyclic AMP嶻惗槾恑傪彽偒丆旍岤惈寣娗昦曄偺敪徢丒恑揥偺梷惂偵娭梌偟偰偄傞偙偲傪僸僩巕媨摦柆慻怐攟梴宯傪梡偄偰徹柧偟偨丅旍岤惈寣娗昦曄敪徢弶婜偵偼娻梷惂堚揱巕p俆俁偺敪尰槾恑偲傾億僩僔僗妶惈偺忋徃偲偄偆憹怋偲偼媡儀僋僩儖偺斀墳偑寣娗暻偵偍偄偰桿敪偝傟偰偄傞偙偲偵偮偄偰傕偡偱偵妋擣嵪傒偱偁傞丅偙偺傛偆偵丆旍岤惈寣娗昦曄偺敪徢丒恑揥婡彉偼暋嶨偱枹夝寛偺揰偑懡偔巆偝傟偰偍傝丆崱屻偺偝傜側傞尋媶偑昁梫偱偁傞偑丆堎側偭偨暘栰偺愱栧壠摨巑偺嬞枾側楢実傪夘偟偰夝寛偝傟傞揰偼彮側偔側偄丅堦憌惛恑傪廳偹偰強婜偺栚揑傪払惉偟偨偄丅

嶲峫帒椏
丒Niimi Y, Azuma H & Hirakawa K. Repeated endothelial removal augments intimal thickening and attenuates EDRF release. Am J Physiol 1994;266:H1348乚56.
丒Azuma H, Hamasaki H, Niimi Y & Matsubara O. Role of endothelin乚l in the neointima formation after endothelial removal in rabbit carotid arteries. Am J Physiol 1994;267:H2259乚67.
丒Azuma H, Sato J, Hamasaki H, Sugimoto A, Isotani E & Obayashi S. Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L乚arginine in the regenerated endothelial cells. Br J Pharmacol 1995; 115:1001乚4.
丒Azuma H, Obayashi S, Hamasaki H, Koyama T & Aso T. Role of endothelium in the human uterine arteries during normal menstrual cycle. Br J Pharmacol 1995;114:902乚8.
丒Azuma H, Hamasaki H, Sato J, Isotani E,丂Obayashi S & Matubara O. Different localization of ETA and ETB receptors in the hyperplastic vasccular wall. J Cardiovasc Pharmacol 1995;25:802乚9.
丒Obayashi S, Aso T, Sato J, Hamasaki H & Azuma H. Intimal hyperplasia in human uterine arteries accompanied by impaired synergism between prostaglandin I2 and nitric oxide. Br J Pharmacol 1996;119:1072乚8.
丒Aoyagi M, Yamamoto M, Azuma H, Nagashima G, Niimi Y, Hirakawa K & Yamamoto K. Expression of p53 protein and p53 gene transcripts in rabbit carotid arteries after balloon denudation. Histochem Cell Biol 1997;107:365乚70.
丒Aoyagi M, Yamamoto M, Azuma H, Nagashima G, Niimi Y, Tamaki M, Hirakawa K & Yamamoto K. Immunolocalization of matrix metalloproteinases in rabbit carotid arteries after balloon denudation. Histochem Cell Biol 1998;109:97乚102.
丒Beppu M, Obayashi S, Aso T, Tamaoki S, Goto M & Azuma H. Correlations among endogenous NOS inhibitors, endothelin乚l and atherosclerotic changes in perimenopausal human uterine arteries. 9th Annual Meeting of the North American Menopause Society, Tronto, Canada, September 1998.
丒Masuda H, Goto M, Tamaoki S & Azuma H. Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan乚induced hyperglycemia. Br J Pharmacol 1999;126:211乚8.